Cardinal Health (CAH) earnings history
Most recent quarter
- Fiscal period
- Q4 2026
- Period end
- Jun 30, 2026
- EPS actual
- $2.91
- EPS estimate
- $2.42
- EPS surprise
- +20.01%
- Revenue surprise
- −2.02%
- Revenue
- $63.7B
- Revenue estimate
- $65.0B
- Reported
- Aug 11, 2026
Cardinal Health reported fiscal Q4 2026 results on August 11, 2026. Earnings per share came in at $2.91, ahead of the $2.42 estimate by 20.01%. Revenue was $63.7 billion, about 2% below the $65.0 billion consensus. Compared with Q4 2025, EPS rose about 40% from $2.08 and revenue rose about 5.8% from $60.2 billion.
The longer record shows strong growth. Annual EPS rose every fiscal year in the table, from $5.06 in 2022 to $5.81 in 2023, $7.47 in 2024, $8.24 in 2025 and $11.26 in 2026. The fiscal 2026 total was about 37% above 2025 and more than double fiscal 2022. The EPS high in the table is $3.17 from Q3 2026, and the revenue high is $65.6 billion from Q2 2026. Quarterly revenue has grown from $44.0 billion in Q1 2022. Over the last 20 quarters, Cardinal Health beat the EPS estimate 17 times. All three misses came in fiscal 2022, and its largest beat was Q1 2023, at 28.04%.
Cardinal Health reported fiscal Q1 between October 30 and November 9 in each of the past five years. That points to late October or early November 2026 for the next report. It will open fiscal 2027.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q4 2026 | Aug 11, 2026 | $2.42 | $2.91 | +20.01% | $63.7B | SEC |
| Q3 2026 | Apr 30, 2026 | $2.79 | $3.17 | +13.43% | $60.9B | SEC |
| Q2 2026 | Feb 5, 2026 | $2.34 | $2.63 | +12.35% | $65.6B | SEC |
| Q1 2026 | Oct 30, 2025 | $2.18 | $2.55 | +16.87% | $64.0B | SEC |
| Q4 2025 | Aug 12, 2025 | $2.04 | $2.08 | +2.09% | $60.2B | SEC |
| Q3 2025 | May 1, 2025 | $2.17 | $2.35 | +8.10% | $54.9B | SEC |
| Q2 2025 | Jan 30, 2025 | $1.78 | $1.93 | +8.14% | $55.3B | SEC |
| Q1 2025 | Nov 1, 2024 | $1.62 | $1.88 | +16.13% | $52.3B | SEC |
| Q4 2024 | Aug 14, 2024 | $1.73 | $1.84 | +6.12% | $59.9B | SEC |
| Q3 2024 | May 2, 2024 | $1.95 | $2.08 | +6.48% | $54.9B | SEC |
| Q2 2024 | Feb 1, 2024 | $1.60 | $1.82 | +13.94% | $57.4B | SEC |
| Q1 2024 | Nov 3, 2023 | $1.40 | $1.73 | +23.23% | $54.8B | SEC |
| Q4 2023 | Aug 15, 2023 | $1.49 | $1.55 | +3.77% | $53.5B | SEC |
| Q3 2023 | May 4, 2023 | $1.49 | $1.74 | +17.03% | $50.5B | SEC |
| Q2 2023 | Feb 2, 2023 | $1.14 | $1.32 | +15.66% | $51.5B | SEC |
| Q1 2023 | Nov 4, 2022 | $0.94 | $1.20 | +28.04% | $49.6B | SEC |
| Q4 2022 | Aug 11, 2022 | $1.18 | $1.05 | −11.23% | $47.1B | SEC |
| Q3 2022 | May 5, 2022 | $1.52 | $1.45 | −4.84% | $44.8B | SEC |
| Q2 2022 | Feb 3, 2022 | $1.23 | $1.27 | +3.15% | $45.5B | SEC |
| Q1 2022 | Nov 9, 2021 | $1.32 | $1.29 | −2.29% | $44.0B | SEC |
Quarterly revenue
Frequently asked questions
When did Cardinal Health (CAH) last report earnings?
Cardinal Health last reported on Aug 11, 2026, covering fiscal Q4 2026.
Did CAH beat earnings estimates?
Yes. Cardinal Health reported EPS of $2.91 for Q4 2026 against a $2.42 estimate — a 20.01% beat.
How much revenue did CAH report last quarter?
Cardinal Health reported $63.7B in revenue for Q4 2026, against a consensus estimate of $65.0B.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.